836 related articles for article (PubMed ID: 8923468)
1. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
[TBL] [Abstract][Full Text] [Related]
3. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor.
Sotiropoulos A; Moutoussamy S; Renaudie F; Clauss M; Kayser C; Gouilleux F; Kelly PA; Finidori J
Mol Endocrinol; 1996 Aug; 10(8):998-1009. PubMed ID: 8843416
[TBL] [Abstract][Full Text] [Related]
5. Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation.
Wang X; Darus CJ; Xu BC; Kopchick JJ
Mol Endocrinol; 1996 Oct; 10(10):1249-60. PubMed ID: 9121492
[TBL] [Abstract][Full Text] [Related]
6. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase.
Frank SJ; Gilliland G; Kraft AS; Arnold CS
Endocrinology; 1994 Nov; 135(5):2228-39. PubMed ID: 7956946
[TBL] [Abstract][Full Text] [Related]
9. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B.
Stofega MR; Herrington J; Billestrup N; Carter-Su C
Mol Endocrinol; 2000 Sep; 14(9):1338-50. PubMed ID: 10976913
[TBL] [Abstract][Full Text] [Related]
10. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms.
Ram PA; Waxman DJ
J Biol Chem; 1999 Dec; 274(50):35553-61. PubMed ID: 10585430
[TBL] [Abstract][Full Text] [Related]
11. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
12. Termination of growth hormone pulse-induced STAT5b signaling.
Gebert CA; Park SH; Waxman DJ
Mol Endocrinol; 1999 Jan; 13(1):38-56. PubMed ID: 9892011
[TBL] [Abstract][Full Text] [Related]
13. Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription.
Sotiropoulos A; Perrot-Applanat M; Dinerstein H; Pallier A; Postel-Vinay MC; Finidori J; Kelly PA
Endocrinology; 1994 Oct; 135(4):1292-8. PubMed ID: 7925092
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling.
Gu F; Dubé N; Kim JW; Cheng A; Ibarra-Sanchez Mde J; Tremblay ML; Boisclair YR
Mol Cell Biol; 2003 Jun; 23(11):3753-62. PubMed ID: 12748279
[TBL] [Abstract][Full Text] [Related]
15. Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children.
Freeth JS; Silva CM; Whatmore AJ; Clayton PE
Endocrinology; 1998 Jan; 139(1):20-8. PubMed ID: 9421393
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
17. Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2.
Rui L; Carter-Su C
Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7172-7. PubMed ID: 10377387
[TBL] [Abstract][Full Text] [Related]
18. Mapping of a cytoplasmic domain of the human growth hormone receptor that regulates rates of inactivation of Jak2 and Stat proteins.
Hackett RH; Wang YD; Sweitzer S; Feldman G; Wood WI; Larner AC
J Biol Chem; 1997 Apr; 272(17):11128-32. PubMed ID: 9111009
[TBL] [Abstract][Full Text] [Related]
19. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase.
Ram PA; Waxman DJ
J Biol Chem; 1997 Jul; 272(28):17694-702. PubMed ID: 9211920
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated by stat5b.
Zhou YC; Waxman DJ
J Biol Chem; 1999 Jan; 274(5):2672-81. PubMed ID: 9915797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]